BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38659482)

  • 1. Growth differentiation factor-15 serum concentrations reflect disease severity and anemia in patients with inflammatory bowel disease.
    Tonkic A; Kumric M; Akrapovic Olic I; Rusic D; Zivkovic PM; Supe Domic D; Sundov Z; Males I; Bozic J
    World J Gastroenterol; 2024 Apr; 30(13):1899-1910. PubMed ID: 38659482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis.
    Matusiewicz M; Neubauer K; Bednarz-Misa I; Gorska S; Krzystek-Korpacka M
    World J Gastroenterol; 2017 Jun; 23(22):4039-4046. PubMed ID: 28652656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.
    Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA
    Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of serum neutrophil gelatinase-associated lipocalin (NGAL), asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) levels, and their relations with disease type and activity in inflammatory bowel diseases.
    Korkmaz H; Asıl M; Temel T; Öztürk B; Kebapçılar L
    Turk J Med Sci; 2021 Oct; 51(5):2403-2412. PubMed ID: 33984894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonenzymatic Serum Antioxidant Capacity in IBD and Its Association with the Severity of Bowel Inflammation and Corticosteroids Treatment.
    Neubauer K; Kempinski R; Matusiewicz M; Bednarz-Misa I; Krzystek-Korpacka M
    Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 30986917
    [No Abstract]   [Full Text] [Related]  

  • 6. TWEAK is not elevated in patients with newly diagnosed inflammatory bowel disease.
    Grimstad T; Skoie IM; Doerner J; Isaksen K; Karlsen L; Aabakken L; Omdal R; Putterman C
    Scand J Gastroenterol; 2017 Apr; 52(4):420-424. PubMed ID: 28040992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is ischemia modified albumin a disease activity marker for inflammatory bowel diseases?
    Kaplan M; Yuksel M; Ates I; Kilic ZM; Kilic H; Kuzu UB; Kayacetin E
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1120-5. PubMed ID: 26642816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum ST2 in inflammatory bowel disease: a potential biomarker for disease activity.
    Boga S; Alkim H; Koksal AR; Ozagari AA; Bayram M; Tekin Neijmann S; Sen I; Alkim C
    J Investig Med; 2016 Jun; 64(5):1016-24. PubMed ID: 27001944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imbalance of tissue inhibitors of metalloproteinases (TIMP) - 1 and - 4 serum levels, in patients with inflammatory bowel disease.
    Kapsoritakis AN; Kapsoritaki AI; Davidi IP; Lotis VD; Manolakis AC; Mylonis PI; Theodoridou AT; Germenis AE; Potamianos SP
    BMC Gastroenterol; 2008 Nov; 8():55. PubMed ID: 19036126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum adipokines in inflammatory bowel disease.
    Waluga M; Hartleb M; Boryczka G; Kukla M; Zwirska-Korczala K
    World J Gastroenterol; 2014 Jun; 20(22):6912-7. PubMed ID: 24944482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anemia in inflammatory bowel disease: prevalence, differential diagnosis and association with clinical and laboratory variables.
    Alves RA; Miszputen SJ; Figueiredo MS
    Sao Paulo Med J; 2014; 132(3):140-6. PubMed ID: 24760213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
    Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
    Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Serum Calprotectin Levels in Patients with Inflammatory Bowel Disease.
    Mori A; Mitsuyama K; Sakemi R; Yoshioka S; Fukunaga S; Kuwaki K; Yamauchi R; Araki T; Yoshimura T; Yamasaki H; Tsuruta K; Morita T; Yamasaki S; Tsuruta O; Torimura T
    Kurume Med J; 2021 Dec; 66(4):209-215. PubMed ID: 34690210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals.
    Voegtlin M; Vavricka SR; Schoepfer AM; Straumann A; Voegtlin J; Rogler G; Ballabeni P; Pittet V; Buser A; Fried M; Beglinger C;
    J Crohns Colitis; 2010 Dec; 4(6):642-8. PubMed ID: 21122574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-320a Monitors Intestinal Disease Activity in Patients With Inflammatory Bowel Disease.
    Cordes F; Demmig C; Bokemeyer A; Brückner M; Lenze F; Lenz P; Nowacki T; Tepasse P; Schmidt HH; Schmidt MA; Cichon C; Bettenworth D
    Clin Transl Gastroenterol; 2020 Mar; 11(3):e00134. PubMed ID: 32352717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum prohepcidin levels in chronic inflammatory bowel diseases.
    Nagy J; Lakner L; Poór VS; Pandur E; Mózsik G; Miseta A; Sipos K
    J Crohns Colitis; 2010 Dec; 4(6):649-53. PubMed ID: 21122575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of IL-23 in enteropathic arthritis patients with inflammatory bowel disease: preliminary results.
    Gheita TA; El Gazzar II; El-Fishawy HS; Aboul-Ezz MA; Kenawy SA
    Clin Rheumatol; 2014 May; 33(5):713-7. PubMed ID: 24384828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum hepcidin concentrations correlate with ferritin in patients with inflammatory bowel disease.
    Mecklenburg I; Reznik D; Fasler-Kan E; Drewe J; Beglinger C; Hruz P;
    J Crohns Colitis; 2014 Nov; 8(11):1392-7. PubMed ID: 24825446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease].
    Ciećko-Michalska I; Fedak D; Mach T
    Przegl Lek; 2010; 67(12):1262-5. PubMed ID: 21591350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel, objective, multivariate biomarkers composed of plasma amino acid profiles for the diagnosis and assessment of inflammatory bowel disease.
    Hisamatsu T; Okamoto S; Hashimoto M; Muramatsu T; Andou A; Uo M; Kitazume MT; Matsuoka K; Yajima T; Inoue N; Kanai T; Ogata H; Iwao Y; Yamakado M; Sakai R; Ono N; Ando T; Suzuki M; Hibi T
    PLoS One; 2012; 7(1):e31131. PubMed ID: 22303484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.